STONY BROOK, N.Y., Dec. 8 /PRNewswire-FirstCall/ -- Applied DNA Sciences, Inc. (OTC Bulletin Board: APDN), a DNA security solutions company, today announced that it has entered into consulting agreements with two experts renowned in their fields of work. John Twilley and Thomas A. Nicolette both bring to APDN years of relevant experience which will be used by APDN as it grows its customer base and pursues new and existing markets for its SigNature(TM) Program. John Twilley is renowned in the field of art conservation with over thirty years of experience. Mr. Twilley has written numerous publications and over 600 unpublished scientific reports on the conservation of art and related topics. Mr. Twilley has held research positions in industry as well as serving as Conservation Scientist at the J. Paul Getty Museum. He held the position of Senior Research Scientist at the Conservation Center of the Los Angeles County Museum of Art and taught art and artifacts conservation at the graduate level within the University of California for twenty years. Mr. Twilley is renowned for his expertise in authentication and conservation of artworks, with a recent emphasis on Asian Art. Mr. Twilley currently has a successful independent practice in conservation science and is assisting APDN in the area of art and collectibles as it pursues this important target market. Fine art and collectibles are especially vulnerable to counterfeiting, forgeries and fraud. APDN believes that its SigNature(TM) DNA Markers can be safely embedded directly in all forms of artwork and collectibles and thus can be used to designate and authenticate these valuables. These DNA Markers can also be embedded in any original supporting documentation related to the artwork or collectibles, in the signature of the artist and in any other relevant material that would provide provenance. Mr. Twilley's expertise in art conservation will assist APDN in the fine art and collectibles market where material compatibility and longevity issues are paramount and where unique security concerns exist, thereby helping to penetrate this important market segment. Thomas A. Nicolette brings over thirty years of experience with security solutions companies to his association with APDN. Having previously held senior management and Board of Director positions in the Authentication and Anti-Shoplifting Industries, Mr. Nicolette brings his knowledge of the industry and the competitive landscape to APDN. Using this knowledge and experience, Mr. Nicolette will be assisting APDN in developing new customers for APDN's SigNature(TM) Program in its identified target markets worldwide. These markets initially include fine wine, art and collectibles, consumer products, digital and recording media, pharmaceuticals and homeland security. Dr. James A. Hayward, CEO of APDN, stated, "We are pleased to be working with these renowned gentlemen and we look forward to the advice and expertise they bring to APDN. Their knowledge and understanding of key issues will be helpful as we further penetrate the target markets that APDN has already identified and they will be instrumental in identifying new target markets." About Applied DNA Sciences, Inc. Applied DNA Sciences, Inc. (APDN) provides botanical DNA encryption, embedment and authentication solutions that can help protect companies, governments and consumers from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion into physical locations and databases. Our common stock is registered under Section 12(g) of the Securities Exchange Act of 1934 and is listed on the Over-The-Counter Bulletin Board under the symbol "APDN." Contact: Debbie Bailey, Applied DNA Sciences, Inc., 25 Health Sciences Drive, Stony Brook, New York 11790; Tel: 631-444- 8090; Fax: 631-444-8848 http://www.ADNAS.com. The statements made by Applied DNA Sciences, Inc. may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe the Company's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA Sciences, Inc. Actual results could differ materially from those projected due to our short operating history, limited market acceptance, market competition and various other factors detailed from time to time in Applied DNA Sciences' SEC reports and filings, including our Registration Statement on Form SB-2 as amended, our Annual Report on Form 10-KSB, filed on January 12, 2006, our subsequent Quarterly Reports on Form 10-QSB, and our Current Reports on Form 8-K. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
SOURCE Applied DNA Sciences, Inc.